Lymph Savior Ingredients: All Six Botanicals, Read Off The Label

A legume whose flowers hold four isoflavones, and by some distance the most studied plant on this label. Nine randomised trials pooled in 2026 gave 37.1 mg to 160 mg of isoflavones a day for between twelve weeks and twelve months, and found a small-to-moderate reduction in hot-flush frequency against placebo (Jiang & Wu, 2026). A separate randomised trial reported improvements in both menopausal symptoms and blood lipids (Yigit & Unsal, 2024), and a third tested fermented isoflavones for overactive bladder (Villadsen, 2023).

None of that is about fluid drainage, and it is worth being clear that red clover is on this label for its traditional reputation as a blood and lymph herb rather than for the trials that exist.

The safety picture is better documented than most botanicals manage. A three-year randomised study in 401 women with a family history of breast cancer used a standardised 40 mg isoflavone product and found no adverse effect on breast density, endometrial thickness, cholesterol or bone mineral density (Powles, 2008). Red clover also contains coumarins, which is the reason anticoagulants appear on the safety page (NCCIH: red clover).

The strongest evidence on this label, and the clearest example of why amounts matter. The active fraction is aescin, a mixture of triterpene saponins, and the trials are built around a standardised dose of it.

A randomised trial in 240 people with chronic venous insufficiency gave dried seed extract standardised to 50 mg of aescin twice daily for twelve weeks, against class II compression stockings and against placebo. Lower-leg volume fell by 43.8 ml on the extract and 46.7 ml on compression, and rose by 9.8 ml on placebo (Diehm, Lancet 1996). The Cochrane review of oral horse chestnut seed extract pooled seven placebo-controlled trials for leg pain and seven for leg volume and concluded that it is an efficacious and safe short-term treatment for the condition (Cochrane HCSE, 2012).

Two things follow. First, this is venous evidence: leaking vein valves and raised venous pressure, not blocked lymphatics. Second, a bottle that does not say how much aescin it holds cannot be compared with those trials at all. Standardised extract is also not the raw conker, which contains aesculin and is toxic (NCCIH: horse chestnut, LiverTox: horse chestnut).

New Jersey tea, and the most traditionally lymphatic plant on this label. In Western herbal practice it is the classic lymphatic remedy, prescribed for swollen nodes and sluggish drainage for well over a century.

The modern literature does not exist. A search of PubMed for Ceanothus americanus returns work on nitrogen-fixing soil bacteria, on butterfly nectar in oak savannas, on plant cyclic peptides, and one clinical article published in the Atlanta Medical and Surgical Journal in 1868 (Phares, 1868). There is no randomised trial, no controlled study, no pharmacokinetic work and no safety series.

That is not a claim that the plant does nothing. It is a statement about how much is known, which is close to nothing, and a reader choosing between this formula and a single standardised extract is entitled to weigh it.

Gotu kola, and the second of the two plants here with dose-specific human trials. Its studied fraction is the total triterpenic fraction, built around asiaticoside, madecassoside and asiatic acid.

A systematic review of thirteen databases found eight randomised studies in chronic venous insufficiency, and pooling the comparable ones showed improvement in transcutaneous gas measurements, the rate of ankle swelling and the venoarteriolar response (Chong & Aziz, 2013). One trial was able to separate a 120 mg daily arm from a 60 mg one, which is the sort of dose-response that makes a result believable (Incandela, 2001). Another gave 60 mg three times a day around flights of more than three hours and measured less ankle swelling than in untreated controls (Cesarone, 2001). The same review is candid that reporting quality was poor enough to leave the risk of bias unclear.

Two published case reports describe liver injury following centella use, one of them in a child (Dantuluri, 2011, Jorge & Jorge, 2005), and the national liver-injury reference carries an entry for it (LiverTox: Centella asiatica). A broad pharmacological review sets out the rest of what is known about the plant (Torbati, 2021).

A large biennial root vegetable, eaten as gobo in Japan and used as an alterative in Western and Chinese herbal traditions. Its reputation in this category is old and its trials are all in other conditions.

Burdock root tea, three cups a day at 2 g of root steeped in 150 ml of boiled water, taken for 42 days alongside standard analgesia, lowered interleukin-6, high-sensitivity CRP and malondialdehyde and raised total antioxidant capacity in knee osteoarthritis (Maghsoumi-Norouzabad, 2016). A 12-week study combined burdock intake with water exercise in women aged 70 to 80 and measured blood lipids and vascular elasticity (Ha, 2018). A 2026 trial gave burdock root powder in polycystic ovary syndrome and measured oxidative stress and inflammation (Taheri, 2026).

The form is worth noticing. Two of those three used a hot-water infusion, and a powder in a capsule is not the same preparation. Burdock also sits in the Asteraceae family with ragweed, chamomile, chrysanthemum and echinacea, which is one of the commonest sources of plant contact allergy (Kljucevsek & Kreft, 2025, Paulsen, 2023).

A caffeinated holly leaf, drunk across southern South America and rich in chlorogenic acids. It is the only stimulant on this label and the label does not quantify it.

A 2025 systematic review and meta-analysis of thirteen randomised trials found improvements in post-prandial glucose, HbA1c and the HOMA index in pre-diabetes, and no significant effect on triglycerides, cholesterol, fasting glucose, waist circumference or BMI (Li, 2025). Eight weeks of three mate servings a day lowered blood pressure and several inflammatory markers in non-habitual drinkers (Bravo, 2025). An encapsulated dry extract delivering 580 mg of caffeoylquinic acids a day for four weeks moved none of its primary parameters, which is the closest trial in form to a capsule (Gebara, 2020, Balsan, 2019).

The adverse events recorded in those trials are the ones a caffeinated leaf would produce: insomnia, tachycardia, headache, mucosal irritation. Separately, the epidemiology of mate drunk very hot is a genuine finding and belongs on any honest page about the plant: pooled case-control data from 1,400 oesophageal cancer cases found risk rising with cumulative consumption and rising further with beverage temperature (Lubin, 2014), and the IARC working group reviewed it alongside very hot beverages generally (IARC Monograph 116, 2018). A room-temperature capsule is not a scalding infusion, and that is exactly the point: the thermal half of that risk does not transfer to this bottle.